fda warning letters glp-1 september 2025 news NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP -1 Weight Loss Drugs FDA Issues 30 Warning Letters

This preservation of physiological patterns distinguishes tesamorelin from other growth hormone modulating compounds and provides researchers with a tool for investigating natural growth hormone regulation mechanisms

CareFirst and CVS breached their duties under ERISA by categorically denying all coverage of Zepbound, regardless of medical necessity, and by failing to follow the plans review process for medically necessary prescription drugs that are not on the plans formulary. Wegovy and Zepbound belong to the same class of medications, known as GLP-1s, and they cost more than $1,000 for a one-month supply

J Clin Invest 123:236246

While it wont cause a false positive for illegal drugs, it will help your doctor understand why your blood sugar, A1c, or cholesterol levels have improved and ensure they interpret your kidney and liver function markers with the correct context